Perceptive Advisors »

Connect Biopharma Hldgs shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 793k 2.82

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apogee Therapeutics (APGE)
Roivant Sciences SHS (ROIV)
Nuvalent Inc-a (NUVL)
Travere Therapeutics (TVTX)
Spdr Series Trust State Street Spd Put Option (XBI)
EXACT Sciences Corporation (EXAS)
Protagonist Therapeutics (PTGX)
Inhibrx Biosciences (INBX)
Edgewise Therapeutics (EWTX)
Immatics SHS (IMTX)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
Perceptive Advisors
BML Capital Management
Knott David M Jr
Richmond Brothers
Renaissance Technologies
Marshall Wace
Citadel Advisors
Jane Street
OMERS Administration Corporation
Susquehanna International
Koa Wealth Management
Millennium Management
Persistent Asset Partners

View all funds holding Connect Biopharma Hldgs